Newsmeme!
Discover News you didn't know existed
Nocturia
News
Related Video News
No related video news stories found.
Related Videos
No related videos found.
Recordati : Silodosin Approved By The European Commission For The Treatment Of The Signs And Symptoms Of Benign ...
Published February 4, 2010, 4:51 am, Medical News Today
Recordati announces that it has been granted Marketing Authorization by the European Commission for the medicinal products Urorec® and Silodyx™ 4 mg, 8 mg, hard capsules, intended for treatment of the signs and symptoms of benign prostatic hyperplasia (BPH). Following national post-authorization procedures, as relevant, product launch could take place by end 2010 or beginning 2011. Benign ...
Vantia Therapeutics' Lead Candidate VA106483 Enters Phase IIb Trial For Nocturia
Published February 3, 2010, 10:02 pm, DrugDiscoveryOnline
Vantia Therapeutics, an emerging pharmaceutical company developing novel, small molecule drugs targeting large, underserved medical markets, recently announces it has begun its planned Phase IIb trial of its lead development compound VA106483 for nocturia
Vantia Therapeutics' Lead Candidate VA106483 Enters Phase IIb Trial For Nocturia
Published February 3, 2010, 6:33 am, Medical News Today
Vantia Therapeutics, an emerging pharmaceutical company developing novel, small molecule drugs targeting large, underserved medical markets, announces it has begun its planned Phase IIb trial of its lead development compound VA106483 for nocturia. The study is a randomised, double-blind, placebo-controlled study and is expected to recruit approximately 120 male patients at 20 centres in the US ...
RECORDATI : SILODOSIN (UROREC(R)/SILODYX) APPROVED BY THE EUROPEAN COMMISSION FOR THE TREATMENT OF THE SIGNS AND ...
Published February 3, 2010, 1:50 am, Marketwire
MILAN, ITALY--(Marketwire - February 3, 2010) - RECORDATI : SILODOSIN (UROREC®/SILODYXT) APPROVED BY THE EUROPEAN COMMISSION FOR THE TREATMENT OF THE SIGNS AND SYMPTOMS OF BPH (BENIGN PROSTATIC HYPERPLASIA) Milan, 3 February 2010 - Recordati announces that it has been granted Marketing Authorization by the European Commission for the medicinal products Urorec® and SilodyxT 4 mg, 8 mg, hard ...
Recordati : Silodosin (Urorec(R)/Silodyx) Approved by the European Commission for the Treatment of the Signs and ...
Published February 3, 2010, 1:46 am, Marketwire via Yahoo! Finance
MILAN, ITALY--(Marketwire - 02/03/10) - RECORDATI : SILODOSIN (UROREC/SILODYX) APPROVED BY THE EUROPEAN COMMISSION FOR THE TREATMENT OF THE SIGNS AND SYMPTOMS OF BPH (BENIGN PROSTATIC HYPERPLASIA) Milan, 3 February 2010 - Recordati announces that it has been granted Marketing Authorization by the European Commission for the medicinal products Urorec and Silodyx 4 mg, 8 mg, hard capsules ...
RECORDATI : SILODOSIN (UROREC®/SILODYX(TM)) APPROVED BY THE EUROPEAN COMMISSION FOR THE TREATMENT OF THE SIGNS AND ...
Published February 3, 2010, 1:43 am, ITNews
(ITnews) - (Hugin) - RECORDATI : SILODOSIN (UROREC®/SILODYX(TM)) APPROVED BY THE EUROPEAN COMMISSION FOR THE TREATMENT OF THE SIGNS AND SYMPTOMS OF BPH (BENIGN PROSTATIC HYPERPLASIA) Milan, 3 February 2010 - Recordati announces that it has been granted Marketing Authorization by the European Commission for the medicinal products Urorec® and Silodyx(TM) 4 mg, 8 mg, hard capsules, intended for ...
Vantia Therapeutics initiates Phase IIb trial of VA106483 for nocturia
Published February 2, 2010, 4:21 am, News-Medical-Net
Vantia Therapeutics, an emerging pharmaceutical company developing novel, small molecule drugs targeting large, underserved medical markets, today announces it has begun its planned Phase IIb trial of its lead development compound VA106483 for nocturia.
Related News Resources:
> HGH News
News Directory
Get started fast by using a pre-defined news directory category
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |